Filter
267
Filtered Results: 267
Text search:
alzheimer
Featured
Recommendations
30
New Publications
42
Language
Document type
No document type
144
Studies & Reports
38
Manuals
26
Guidelines
25
Training Material
23
Resource Platforms
4
Fact sheets
4
Strategic & Response Plan
3
Countries / Regions
Global
22
India
13
Western and Central Europe
11
Eastern Europe
8
Ukraine
7
Latin America and the Carribbean
6
Russia
6
Kenya
5
Chile
4
Germany
4
Asia
3
Venezuela
3
Indonesia
3
El Salvador
2
Africa
2
Jamaica
2
Argentina
2
Bangladesh
2
South Africa
2
Ghana
1
Sierra Leone
1
Togo
1
Cameroon
1
Iran
1
Estonia
1
Peru
1
Philippines
1
USA
1
Haiti
1
South–East Asia Region
1
Paraguay
1
East and Southern Africa
1
Sri Lanka
1
Ethiopia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
53
Public Health
37
Clinical Guidelines
10
Capacity Building
2
Women & Child Health
2
Pharmacy & Technologies
2
Toolboxes
Mental Health
151
COVID-19
16
Disability
14
Caregiver
12
NCDs
11
Planetary Health
10
Pharmacy
8
Refugee
6
Global Health Education
6
Conflict
4
TB
2
Social Ethics
2
Rapid Response
1
HIV
1
Zika
1
n Deutschland leben zurzeit etwa 22 Millionen Menschen mit Migrationshintergrund, davon sind über 2,23 Millionen älter als 65 Jahre. Eine Studie des Robert Koch-Instituts (2008) kam zu dem Ergebnis, dass Migrantinnen und Migranten ab 55 Jahren höhere Gesundheitsrisiken aufweisen als vergleichbare...
La demencia es una enfermedad gravemente incapacitante para aquellos que la padecen y suele ser devastadora para sus cuidadores y familiares. Se estima que en la actualidad 35.6 millones de personas viven con demencia a nivel mundial. Este número se habrá casi duplicado para el 2030 y más que tri...
The report “Dementia: a public health priority” has been jointly developed by WHO and Alzheimer's Disease International. The purpose of this report is to raise awareness of dementia as a public health priority, to articulate a public health approach and to advocate for action at international a...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C...
Many determinants are known to affect brain health at different stages of life. The position paper provides a conceptual framework for what brain health is and how brain health can be optimized throughout life with actions across the following clusters of determinants: physical health, healthy envir...
Q9: For carers of people with dementia, do interventions (psychoeducational, cognitive-behavioural therapy counseling/case management, general support, training of caregivers, multi-component interventions and miscellaneous interventions) when compared to placebo/comparator, produce benefits/harm in...
Q8: For people with dementia, what is the role of a medical review (including comorbid physical and mental conditions and medication use)?
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Доклад Секретариата по теме Деменция
Материалы научно-практической конференции с международным участием «Достижения в нейробиологии и терапии болезни Альцгеймера», посвященной памяти профессора Э....
Q10: For carers of people with dementia, does respite care when compared to care as usual, produce benefits/harm in the specified outcomes?
Q5: For people with dementia, which cognitive/psychosocial interventions (such as cognitive stimulation, cognitive rehabilitation, reality orientation, reminiscence therapy) when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Q7: For people with dementia, who should be told of the diagnosis and how should the diagnosis be delivered?
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Brief review of selected topics
The following pages provide a focus on selected areas in relation to neurology. The specialists who contributed the reviews are listed in the Project Team and Partners
Neurology Atlas (2004)
March 28, 2017https://doi.org/10.1371/journal.pmed.1002274
PLoS Med 14(3): e1002274. https://doi.org/10.1371/journal.pmed.1002274
November 3, 2009https://doi.org/10.1371/journal.pmed.1000176
PLoS Med 6(11): e1000176. https://doi.org/10.1371/journal.pmed.1000176
